Form 8-K - Current report:
SEC Accession No. 0001193125-26-335200
Filing Date
2026-08-05
Accepted
2026-08-05 16:20:16
Documents
11
Period of Report
2026-08-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K btmd-20260805.htm   iXBRL 8-K 47790
2 EX-99.1 btmd-ex99_1.htm EX-99.1 690910
3 GRAPHIC img137956444_0.gif GRAPHIC 3098
  Complete submission text file 0001193125-26-335200.txt   878696

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT btmd-20260805.xsd EX-101.SCH 24814
14 EXTRACTED XBRL INSTANCE DOCUMENT btmd-20260805_htm.xml XML 4706
Mailing Address 1875 W. WALNUT HILL LN #100 IRVING TX 75038
Business Address 1875 W. WALNUT HILL LN #100 IRVING TX 75038 972-486-9346
biote Corp. (Filer) CIK: 0001819253 (see all company filings)

EIN.: 851791125 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40128 | Film No.: 261243898
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)